98%
921
2 minutes
20
Purpose: To investigate the impact of several allergic diseases on the development of keratoconus (KC) from a genetic perspective.
Methods: Data from multiple genome-wide association studies involving European ancestry individuals were used. Ultimately, 613 allergic conjunctivitis (AC) cases and 474,657 controls, 4387 allergic rhinitis (AR) cases and 471,273 controls, 4859 allergic asthma cases and 135,449 controls, 1169 allergic urticaria cases and 212,464 controls, 22,474 atopic dermatitis cases and 774,187 controls, and 311 KC cases and 209,287 controls were included. Then inverse-variance weighted (IVW) method, potential pleiotropy, heterogeneity, and leave-one-out analyses were assessed to investigate the causal effects of those allergic diseases on KC.
Results: IVW estimates indicated that allergic asthma promoted the development of KC (IVW odds ratio [OR] = 2.18; 95% confidence interval [CI], 1.007-4.707; P = 0.048). However, the IVW estimates show that AC (IVW OR = 1.02; 95% CI, 0.960-1.086; P = 0.513), AR (OR = 0.26; 95% CI, 0.037-1.754; P = 0.165), atopic dermatitis (IVW OR = 1.50; 95% CI, 0.942-2.395; P = 0.088), allergic urticaria (IVW OR = 1.11; 95% CI, 0.822-1.511; P = 0.485) are not significantly causally associated with KC.
Conclusions: Allergic asthma may promote KC by increasing allergy-related ocular inflammation.
Translational Relevance: The possibility of increased KC in patients with allergic asthma should be considered.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11993130 | PMC |
http://dx.doi.org/10.1167/tvst.14.4.14 | DOI Listing |
Turk J Pediatr
September 2025
Division of Allergy and Asthma, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Türkiye.
Animal allergens, particularly those from cats, dogs, and horses, are significant risk factors for the development of allergic diseases in childhood. Managing animal allergies requires allergen avoidance and, when this is not feasible, specific immunotherapy. Patient history remains the cornerstone of diagnosis, providing the foundation for diagnostic algorithms.
View Article and Find Full Text PDFAllergol Immunopathol (Madr)
September 2025
Quirón Dexeus University Hospital, Nevot Casas Paediatric and Family Clinic, Calle Sabino Arana, Barcelona, Spain.
is an ubiquitous mold commonly found in both outdoor and indoor environments. It is a common airborne mold recognized as a significant aeroallergen linked to pediatric allergic rhinitis and asthma. Although sensitization rates in children vary regionally, evidence suggests that allergy significantly impacts pediatric respiratory health and as its exposure worsens, respiratory outcomes in susceptible pediatric populations .
View Article and Find Full Text PDFAllergol Immunopathol (Madr)
September 2025
Department of Pulmonary Medicine, Rajasthan Hospital, Jaipur, India.
Saline nasal irrigation provides symptom relief in allergic rhinitis (AR), but the optimal saline concentration remains uncertain. The comparative efficacy of 3% hypertonic saline nasal irrigation (HSNI) versus 0.9% isotonic saline is still debated.
View Article and Find Full Text PDFAllergol Immunopathol (Madr)
September 2025
Department of Pediatrics, Ankang Hospital of Traditional Chinese Medicine, Ankang, China;
Allergic asthma is an inflammatory airway disease influenced by genetic and environmental factors and orchestrated by imbalance between T helper 1 cell (Th1) and two immune responses. Inflammation contributes to pathological changes and remodeling in tissues such as the vascular, lung, heart, and beds. The purpose for this study was to evaluate the effects of allergic asthma on heart pathology and remodeling.
View Article and Find Full Text PDFAllergol Immunopathol (Madr)
September 2025
Department of Immunology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran;
Asthma, a respiratory tract disease, is characterized by inflammation and obstruction of airway. Inflammatory cells play a significant role in allergic asthma, and there is no complete cure for asthma. One of the new approaches in medicines is nanoparticle-base treatment.
View Article and Find Full Text PDF